These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7910870)

  • 1. [New antisecretory drugs in the treatment of ulcer].
    Sheptulin AA
    Klin Med (Mosk); 1994; 72(1):12-5. PubMed ID: 7910870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intragastric pH modifications induced by antisecretory treatments].
    Vallot T; Galmiche JP; Gouilloud-Celle S; Mignon M
    Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):80C-87C. PubMed ID: 1680770
    [No Abstract]   [Full Text] [Related]  

  • 3. [Peptic ulcer and drug therapy].
    Tsuneoka K
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):1-2. PubMed ID: 1673699
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of antimuscarinic agents, H2-blockers and omeprazole on rat chronic gastric ulcer after long- and short-term administration.
    Chiavarini M; Morini G; Barocelli E; Impicciatore M; Bordi F
    Farmaco Sci; 1988 May; 43(5):479-87. PubMed ID: 2906011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
    Karasawa H; Miwa T
    Nihon Rinsho; 1992 Jan; 50(1):74-80. PubMed ID: 1347333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!].
    Vallot T; Mignon M
    Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433
    [No Abstract]   [Full Text] [Related]  

  • 7. [Refractory duodenal ulcer: an emerging therapeutic problem].
    Bianchi Porro G; Parente F
    Medicina (Firenze); 1988; 8(1):27-33. PubMed ID: 2906398
    [No Abstract]   [Full Text] [Related]  

  • 8. [The medical therapy of peptic ulcer. The state of the art].
    Perroni GB; De Matteis G; Pellizzeri F; Cassone A; Malara F
    Minerva Chir; 1992 Apr; 47(7):607-12. PubMed ID: 1350332
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic achlorhydria: for which diseases, when and for how long?].
    Koop H; Arnold R
    Dtsch Med Wochenschr; 1988 Mar; 113(13):516-8. PubMed ID: 2894969
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peptic ulcer: current therapy].
    Pieragnoli E
    G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs in the treatment of gastric and duodenal ulcer.
    Langman MJ
    Drugs; 1977 Aug; 14(2):105-15. PubMed ID: 19225
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical problems in the diagnosis and treatment of duodenal ulcer and stomach ulcer. A report].
    Andersen D; Rune SJ; Søltoft J; Wulff HR
    Ugeskr Laeger; 1984 Apr; 146(14):1055-7. PubMed ID: 6145240
    [No Abstract]   [Full Text] [Related]  

  • 14. [Duodenal peptic ulcer. Medical therapy].
    Villalobos Pérez JJ
    Rev Gastroenterol Mex; 1984; 49(3):179-84. PubMed ID: 6151237
    [No Abstract]   [Full Text] [Related]  

  • 15. [The place of histamine H2 receptor antagonists in the treatment of diseases of the gastrointestinal tract].
    Visnovský P; Valentík M
    Cesk Gastroenterol Vyz; 1979 Jul; 33(5):312-5. PubMed ID: 41642
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of H2-blocking drugs on the surgical therapy of peptic ulcer].
    Procacciante F; Pronio A; Perri S; Di Nardo A; Montesani C; Citone G; Catani M; Ribotta G
    Minerva Chir; 1987 Oct; 42(19):1491-4. PubMed ID: 2891085
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat.
    Kromer W; Gönne S; Riedel R; Postius S
    Pharmacology; 1990; 41(6):333-7. PubMed ID: 1982899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptic ulcer disease: physiology and pathophysiology.
    Holt KM; Isenberg JI
    Hosp Pract (Off Ed); 1985 Jan; 20(1):89-93, 96-101, 104-6. PubMed ID: 2856923
    [No Abstract]   [Full Text] [Related]  

  • 20. [Surgical treatment of gastroduodenal ulcer disease. Our experience after the advent of H2-antagonist drugs].
    Carrella G; Salomoni C; De Anna D; Pozza E; Sortini A; Guerrera C; Pansini GC; Marcello D; Vettorello GF
    Minerva Chir; 1987 Oct; 42(19):1483-5. PubMed ID: 2891084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.